Jan 03, 2019
ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
Dec 21, 2018
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way
Nov 28, 2018
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies
Nov 26, 2018
Apexigen To Present At Piper Jaffray's 30th Annual Healthcare Conference
Nov 20, 2018
ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments
Nov 15, 2018
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210
Nov 13, 2018
Exponential Growth Expected for Antibody-drug Conjugates (ADCs) - CDMOs Continue to Play a Major Role in Manufacturing and Co-Development
Nov 13, 2018
Agenus to Present at the 2018 Jefferies London Healthcare Conference
Nov 13, 2018
ProMIS Neurosciences Announces Third Quarter 2018 Results
Nov 13, 2018
Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy
Nov 07, 2018
Alligator Bioscience to Receive Million-dollar Payments - AbClon Partner Exercises Option
Nov 06, 2018
Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Oct 20, 2018
Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018
Oct 16, 2018
CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
Oct 11, 2018
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease
Oct 09, 2018
Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018
Oct 04, 2018
BioAtla Congratulates James Allison, Ph.D. For Receiving Nobel Prize
Sep 06, 2018
RubrYc Therapeutics Winner of the 2018 Xcelerate Startup Pitch Competition
Aug 29, 2018
ProMIS Neurosciences Issues Narrated Overview of Second Quarter 2018 Results
Aug 28, 2018
GT Biopharma Announces Initiation of OXS-1550 in Combination With a Multi-billion Dollar Oncology Drug